Immuneering (IMRX) Q2 2025 Earnings

5MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.58
-0.53
-0.47
-0.42

Details

Expected EPS
-0.526667
Actual EPS
-0.42
Surprise EPS
0.11
Surprise Percent
+20.25%

Description

Immuneering (IMRX) has reported earnings of -0.42 per share for Q2 2025.

0 Comments

Share your thoughts